Stay updated on Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.

Latest updates to the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check21 days agoChange DetectedA notice appears at the top of the page about NIH website updates and the transition from using “Artificial Intelligence” to “Super Intelligence” in federal agency content.SummaryDifference0.8%

- Check28 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check35 days agoChange DetectedThe site revision label in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check56 days agoChange DetectedThe Study Record History now shows a new revision entry, Revision: v3.7.0, while the previous Revision: v3.6.6 is removed from the history. This indicates a system release update to the record page rather than a change to the study data or core content.SummaryDifference0.1%

- Check77 days agoChange DetectedVersion v3.6.6 was added to the study record history, and the previous v3.6.5 entry was removed from the log. This updates the version history to reflect the latest revision of the study record.SummaryDifference0.1%

Stay in the know with updates to Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.